SecBot SecBot

BRQL

DYNAMIC AEROSPACE SYSTEMS Corp
OTC· Services-Computer Processing & Data Preparation· Inc. NV· CIK 0001854526 Software & IT
$0.2274 −0.02 (−8.99%)
Oct 26 4:00 PM ET · prev $0.2499
1 year
−61.4%
from $0.5897 · Oct 28
30 days
+8.4%
from $0.2099
52-week range
$0.1279–1.02
−78% from high · low Sep 16
Avg volume 20D
9.4K
Oct 6 spike 44.6K
Short interest
757
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest BEARISH Dynamic Aerospace Systems entered into multiple related-party debt agreements with its CEO and COO…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • TrendUPTREND

    18% above its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Oct 22, 2026 SEC
Dynamic Aerospace Systems entered into multiple related-party debt agreements with its CEO and COO, formalizing and…
8-K · Impact 6/10
Jun 25, 2026 SEC
Dynamic Aerospace Systems Corp closed the initial tranche of a private placement, issuing 357,143 shares and warrants…
8-K · Impact 5/10
May 15, 2026 SEC
Dynamic Aerospace Systems reported a Q1 2026 GAAP net loss of $1.05M, with an adjusted operational loss of $773k. No…
8-K · Impact 4/10
Apr 9, 2026 Insider
HOOPS ROBIN was granted 500,000 shares
CHIEF FINANCIAL OFFICER
Dec 12, 2025 Insider
HAIL JEFFREY was granted 1,500,000 shares
CHIEF OPERATING OFFICER
Dec 12, 2025 Insider
Kantrowitz Ian was granted 1,500,000 shares
VICE PRESIDENT
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Mar 24, 2026
Clinical Trial
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
Phase 2 · COMPLETED

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Apr 9, 2026
HOOPS ROBIN
CHIEF FINANCIAL OFFICER
AWARD500,000 sh
Dec 12, 2025
HAIL JEFFREY
CHIEF OPERATING OFFICER
AWARD1,500,000 sh
Dec 12, 2025
Kantrowitz Ian
VICE PRESIDENT
AWARD1,500,000 sh
Dec 12, 2025
RIGNEY SHANNON LEE
VICE PRESIDENT
AWARD1,500,000 sh
Oct 1, 2025
RICH RON J
Director
AWARD100,000 sh

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$0.00
Next QNoneNoneNo data$0.00
Current FYNoneNoneNo data$0.00
Next FYNoneNoneNo data$0.00

Short side

FINRA· Oct 15, 2026
757
shares short
1.0
days to cover

SecBot reports

5 filings · 0 bullish · 4 bearish · 1 neutral
All BRQL filing & press-release reports (5)